| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042212 Method of reducing CRF receptor mRNA |
| 02/24/2005 | US20050042209 Enhancing the induction apoptosis in a MUC1 expressing cancer cell by a pro-apoptotic drugs; antiproliferative agents |
| 02/24/2005 | US20050042208 Incubating precursor cell capable of differentiating to cytotoxic T cell with antigen presenting cell in presence of substance having binding activity to CD44, fibronectin, regulator of signal emitted by growth factor, and/or inhibitor of binding to growth factor receptor; immunotherapy |
| 02/24/2005 | US20050042206 Viral vectors having reduced virulence |
| 02/24/2005 | US20050042204 Method to protect transgenes from silencing |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | US20050042143 Plastic plate and plastic plate assembly |
| 02/24/2005 | US20050040550 High throughput screening for novel bioactivities |
| 02/24/2005 | US20050040043 Receptor binding assay to separate and purifying the target DNA or RNA molecules from a sample |
| 02/24/2005 | DE20122302U1 Variante des Modifizierten Vaccinia-Ankara-Virus Modified version of the vaccinia Ankara virus |
| 02/24/2005 | DE10006462B4 Produktion nicht-kariogener Zucker in transgenen Pflanzen Non-cariogenic sugar production in transgenic plants |
| 02/24/2005 | CA2852159A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | CA2575926A1 Canine specific growth hormone releasing hormone |
| 02/24/2005 | CA2539295A1 Improved sirna molecule and method of suppressing gene expression with the use of the same |
| 02/24/2005 | CA2538987A1 A method for improving plant transformation efficiency by adding copper ion |
| 02/24/2005 | CA2537065A1 Method for producing rose with altered petal colors |
| 02/24/2005 | CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | CA2536146A1 Splice variants of erbb ligands, compositions and uses thereof |
| 02/24/2005 | CA2535863A1 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | CA2535860A1 Method for detecting transient protein interactions and drug discovery |
| 02/24/2005 | CA2535683A1 Stem cell beacon |
| 02/24/2005 | CA2535680A1 Vigilant cells |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535515A1 Cd20-binding polypeptide compositions |
| 02/24/2005 | CA2535508A1 A new class of .alpha.2.delta. calcium channel subunits |
| 02/24/2005 | CA2535261A1 Prion-specific peptide reagents |
| 02/24/2005 | CA2535255A1 Improved halohydrin dehalogenases and related polynucleotides |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | CA2534563A1 Antibodies to c-met |
| 02/24/2005 | CA2534467A1 New diabetes type 2 animal model |
| 02/24/2005 | CA2533921A1 Binding constructs and methods for use thereof |
| 02/24/2005 | CA2533838A1 Improved ketoreductase polypeptides and related polynucleotides |
| 02/24/2005 | CA2533830A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | CA2533382A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | CA2532576A1 Npc1l1 (npc3) and methods of use thereof |
| 02/24/2005 | CA2532557A1 Methods and compositions for determination of glycated proteins |
| 02/24/2005 | CA2532027A1 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | CA2529658A1 Engineering single-gene-controlled staygreen potential into plants |
| 02/24/2005 | CA2529553A1 Ribonucleases and methods of making them recombinantly |
| 02/24/2005 | CA2526595A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | CA2526339A1 Polyvalent immunogen |
| 02/24/2005 | CA2526120A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | CA2525969A1 Intron fusion proteins, and methods of identifying and using same |
| 02/24/2005 | CA2525647A1 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | CA2524305A1 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/24/2005 | CA2516425A1 Rna interference compositions and methods |
| 02/23/2005 | EP1508623A1 Method of specifying snp |
| 02/23/2005 | EP1508620A1 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 02/23/2005 | EP1508619A1 Novel promoter |
| 02/23/2005 | EP1508614A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/23/2005 | EP1508576A1 Efficient production of IgA in recombinant mammalian cells |
| 02/23/2005 | EP1508572A1 PROTEIN INDUCING CELL DEATH OF i HELICOBACTER PYLORI /i |
| 02/23/2005 | EP1508340A1 Insulin resistance improving agents |
| 02/23/2005 | EP1508339A1 Tuberculosis vaccine |
| 02/23/2005 | EP1508273A1 Adiponectin-knoucout nonhuman animal |
| 02/23/2005 | EP1508047A2 Method for identifying immunoreactive peptides |
| 02/23/2005 | EP1508045A1 Methods of detecting target molecules and molecular interactions |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/23/2005 | EP1507874A2 Compositions and processes for inhibiting gene expression using polynucleotides |
| 02/23/2005 | EP1507873A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use |
| 02/23/2005 | EP1507872A2 Protein c polymorphisms |
| 02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
| 02/23/2005 | EP1507865A2 The frog prince, a transposon vector for gene transfer in vertebrates |
| 02/23/2005 | EP1507864A1 A method for production of plants with suppressed photorespiration and improved co2 fixation |
| 02/23/2005 | EP1507863A1 Plasmid stabilisation in vivo |
| 02/23/2005 | EP1507862A2 Modified tetracycline repressor protein compositions and methods of use |
| 02/23/2005 | EP1507861A2 Vaccines |
| 02/23/2005 | EP1507860A2 Dynamic action reference tools |
| 02/23/2005 | EP1507857A1 Novel pectinases and uses thereof |
| 02/23/2005 | EP1507856A1 Regulation of human serine/threonine kinase |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507852A2 Nucleic acids and proteins with thioredoxin reductase activity |
| 02/23/2005 | EP1507851A1 Method for assembling sub units into capsoides |
| 02/23/2005 | EP1507850A1 A method for generating antigen-presenting cells |
| 02/23/2005 | EP1507802A1 Transformed fungi for production of recombinant proteins |
| 02/23/2005 | EP1507795A1 Tumour-associated peptides that bond to mhc molecules |
| 02/23/2005 | EP1507791A2 Antisense antiviral agent and method for treating ssrna viral infection |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507593A1 Sample carrier having releasable locking mechanism |
| 02/23/2005 | EP1507561A2 Compositions for delivering nucleic acids to cells |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507551A2 The functional role and potential therapeutic use of pacap, vip and maxadilan in relation to adult neural stem or progenitor cells |
| 02/23/2005 | EP1456645A4 Methods for determining the prognosis for cancer patients using tucan |
| 02/23/2005 | EP1317466B1 Synthons for oligonucleotide synthesis |
| 02/23/2005 | EP1315829A4 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
| 02/23/2005 | EP1169466A4 Synthesis of 1,2,3,4-tetrahydroxybenzenes and 1,2,3-trihydroxybenzenes using myo-inositol-1-phosphate synthase and myo-inositol 2-dehydrogenase |
| 02/23/2005 | EP1114314B1 Device comprising a plurality of analysis sites on a support and method of manufacturing the device |
| 02/23/2005 | EP1068311A4 Methods and means for obtaining modified phenotypes |
| 02/23/2005 | EP1035870B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | CN1585823A Genes coding for DNA replication proteins and for proteins related to pathogenesis |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585776A Detection and identification of enteric bacteria |
| 02/23/2005 | CN1584036A Method for obtaining transgenic grass for sheep |
| 02/23/2005 | CN1584035A Expressions of recombined swine lactoferrin and its peptide by pichia |